HelloSpore
HelloSpore
My Account
Shop Now →

🔒 256bit SSL encrypted checkout

Your Cart (0)
🛒
Your cart is empty
Home/Research Hub/MDMA & Psilocybin Reverse Long-COVID Symptoms: The Case Report Explained
🎙 PodcastClinical Research

MDMA & Psilocybin Reverse Long-COVID Symptoms: The Case Report Explained

A podcast breaking down the published clinical case report of a Long-COVID patient whose persistent fatigue, brain fog, and post-exertional malaise substantially resolved following MDMA and psilocybin-assisted therapy — examining proposed mechanisms and what this single case means for the emerging research agenda.

🎙

Content Coming Soon

This resource is being prepared and will be available shortly.

psilocybinMDMALong COVIDpost-COVIDpsychedelic therapyneuroinflammationpsilocybe cubensis

Source Research Papers

Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar.

Chopra, H., Furnish, T., Verduzco-Gutierrez, M., Jevotovsky, D. S., & Castellanos, J. (2024). Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report. Clinical Case Reports, 12, e8791. https://doi.org/10.1002/ccr3.8791

Shop Related Spores

Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.

Golden Teacher Spores →Tidal Wave Spores →
Back to Research Hub